SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Chemicals & Pharmaceuticals clarifies on news item

16 Sep 2015 Evaluate

With reference to the news reported in Business Line, 16/09/2015, ‘Orchid Pharmaceuticals in talks with banks to rejig debt’, Orchid Chemicals & Pharmaceuticals has clarified that the company is currently in talks with banks to explore the possibility of converting its rupee debt into dollar denominated debt. This plan is to try and reduce the interest burden on the company which will ultimately be beneficial to the companys bottom line.They will keep the stock exchanges informed as and when further developments take place.'

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

570.50 6.40 (1.13%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×